Similarly, female patients in the NAFLD group also had lower serum PRL concentration [5.66 (4.67, 9.03) vs. 9.01 (6.31, 11.60) ug/L, P = 0.009] than the non-NAFLD patients. The gene discussed is PRL; the disease is metabolic dysfunction-associated steatotic liver disease.